DWTX earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -0.14. Updated 2026-07-23.
Dogwood Therapeutics (DWTX) Research Hub
Dogwood Therapeutics (DWTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.94 USD (0.00%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.14, market cap 0.00B. This hub links to the full technical, earnings and options research available for DWTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.94 USD (0.00%) |
| 52-week range | 1.28 USD – 2.8 USD |
| Trend regime | Range |
| 14-day RSI | 54 (Neutral) |
| Trailing P/E | -0.14 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for DWTX
Covered Call on DWTX: how it works, illustrative setup around the real 1.94 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DWTX: how it works, illustrative setup around the real 1.94 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DWTX: how it works, illustrative setup around the real 1.94 USD price, max profit/loss, breakeven and when to use it. Educational.
DWTX technical analysis: range, last 1.94 USD, RSI 54, 52w range 1.28 USD–2.8 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is DWTX in?
Dogwood Therapeutics (DWTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DWTX in an uptrend or downtrend?
As of 2026-09-11, DWTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DWTX's trailing P/E ratio?
DWTX's trailing P/E is -0.14, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does DWTX next report earnings?
DWTX is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.13 USD.